Actinium Lawsuit Submission Form | Class Action Lawsuit List

First Name

Last Name

Phone

Street Address

City

State

Zip

Shares Owned

Purchase Date

Estimated Loss

Class Action Lawsuit List does not share your information with others. There is no cost or obligation for you to submit.

Investigation Details

Actinium issued a press release on August 5, 2024, “announc[ing] a regulatory update on the Company’s planned Biologics License Application (‘BLA’) filing for Iomab-B in patients with active relapsed or refractory acute myeloid leukemia (‘r/r AML’).” The press release stated, in relevant part, that the U.S. Food And Drug Administration had “determined that the Phase 3 SIERRA trial is not adequate to support a BLA filing for Iomab-B despite its statistically significant primary endpoint[.]”

Following this news, Actinium’s stock price fell over 59% the same day.

Active Cases

Ticker Symbol	Company Name	Join Deadline	Join
WOLF	Wolfspeed, Inc.	January 17, 2025	Join
SUI	Sun Communities, Inc.	February 10, 2025	Join
SAVA	Cassava Sciences, Inc.	February 10, 2025	Join
APLT	Applied Therapeutics, Inc.	February 18, 2025	Join

Actinium Pharmaceuticals, Inc.

ATNM

Actinium Pharmaceuticals, Inc. Form

Active Cases